2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Sunday, November 8, 2015

2:30PM-4:00PM: Abstract Number: 927

Ultrasound Assessment of Heel Entheses in Spondyloarthritis Patients: A Comparative Study with Radiography and Magnetic Resonance Imaging

Imaging of Rheumatic Diseases I: Ultrasound

2:30PM-4:00PM: Abstract Number: 942

Update in the Management of Biologic Response Modifiers and Disease-Modifying Antirheumatic Drugs Following Coccidioidomycosis

Miscellaneous Rheumatic and Inflammatory Diseases I

2:30PM-4:00PM: Abstract Number: 1001

What Is the Most Cost-Effective Physical Therapy Strategy to Treat Knee Osteoarthritis?

ARHP I: Exemplary Abstracts

2:30PM-4:00PM: Abstract Number: 914

When Fibromyalgia Criteria Misclassify

Fibromyalgia: Insights Into Diagnostic Criteria and Symptom Epidemiology

4:30PM-6:00PM: Abstract Number: 1087

“It Was Just My Right Pace”: A Qualitative Study Exploring Yoga Practice in Adults with Rheumatoid Arthritis

ACR/ARHP Combined Abstract Session: Rehabilitation

4:30PM-6:00PM: Abstract Number: 1018

A 32-Mer Aggrecan Fragment Generated through Adamts-4/5 and MMP-Mediated Cleavage Can Directly Excite Nociceptive Neurons

Pain: Basic Aspects

4:30PM-6:00PM: Abstract Number: 1017

A Novel Mechanism of Arthritis-Induced Pain: Activation of Sensory Neurons By Autoantibodies

Pain: Basic Aspects

4:30PM-6:00PM: Abstract Number: 1054

A Potential Role of Type III Interferon in the Glandular Involvement of Sjögren’s Syndrome

Sjögren's Syndrome I: Basic Insights

4:30PM-6:00PM: Abstract Number: 1020

Abnormal Resting State Functional Connectivity in Chronic Fatigue Syndrome Patients: An Arterial Spin-Labeling fMRI Study

Pain: Basic Aspects

4:30PM-6:00PM: Abstract Number: 1032

Adherence Patterns to American Academy of Ophthalmology Guidelines for Hydroxychloroquine Baseline Screening: Quality Assurance Assessment Utilizing Highmark Claims Data

Quality Measures and Quality of Care

4:30PM-6:00PM: Abstract Number: 1081

Administration of Patient Reported Outcome Measurement Information System (PROMIS) Instruments By Computer Adaptive Testing in Patients with Systemic Vasculitis

Vasculitis I

4:30PM-6:00PM: Abstract Number: 1063

Admissions and Readmissions of Patients with Systemic Lupus Erythematosus Is a Major Cause of Direct and Indirect Health Care Costs

Systemic Lupus Erythematosus - Clinical Aspects and Treatment II: Patient-Reported Measures, Outcomes and Reporting

4:30PM-6:00PM: Abstract Number: 1082

ANCA-Negative and Myeloperoxidase-ANCA-Positive Patients with Granulomatosis with Polyangiitis: Clinical Manifestations and Risk of Relapse

Vasculitis I

4:30PM-6:00PM: Abstract Number: 1056

Aquaporin Gene Therapy Corrects Bone Morphogenetic Protein 6 Associated Exocrine Gland Dysfunction in Mouse Model of Sjögren’s Syndrome

Sjögren's Syndrome I: Basic Insights

4:30PM-6:00PM: Abstract Number: 1057

Are Ankylosing Spondylitis, Psoriatic Arthritis and Undifferentiated Spondylarthritis Associated with an Increased Risk of Cardiovascular Disease?

Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Clinical Aspects and CoMorbidities

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].